10-1074 - National Institute of Allergy and Infectious Diseases, Rockefeller University, Gilead
3BNC117 - Rockefeller University, Cornell University, Frontier Biotech, Gilead
lefitolimod (MGN1703) - Mologen, OncXerna Therap, iPharma
TITAN: Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV (clinicaltrials.gov) - Apr 23, 2021 - P2a; N=48; Recruiting; Sponsor: University of Aarhus; Trial completion date: Feb 2021 ➔ Feb 2023; Trial primary completion date: Jul 2020 ➔ Jul 2022 
Clinical • Trial completion date • Trial primary completion date • Human Immunodeficiency Virus • Immunology • Infectious Disease • CD4
http://clinicaltrials.gov/ct2/show/NCT03837756
 
Apr 23, 2021
 
Prev Next